Reduction of Oncogene Expression in Cancer Cells Using siRNA Delivery Systems
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Eun-Joong ( | - |
dc.contributor.author | Kim, Young-Bong | - |
dc.contributor.author | Choi, Han-Gon | - |
dc.contributor.author | Shim, Chang-Koo ( | - |
dc.contributor.author | Oh, Yu-Kyoung | - |
dc.date.accessioned | 2021-06-23T23:03:35Z | - |
dc.date.available | 2021-06-23T23:03:35Z | - |
dc.date.created | 2021-02-18 | - |
dc.date.issued | 2005-10 | - |
dc.identifier.issn | 2093-5552 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/45704 | - |
dc.description.abstract | Recently, siRNA has been emerging as new therapeutic agents for various diseases such as cancers and infectious diseases. However, the evaluation for delivery systems for siRNA has not been fully done. In this study, we designed and delivered siRNA of oncogenic E6 and E7 proteins to several cell lines and tested the delivery efficiencies of various cationic nonviral delivery vectors. Of cationic delivery systems tested in this study, lipid-based Lipofectamine revealed higher delivery efficiency of siRNA to cervical cancer cell line, SiHa, compared to other delivery systems. Notably, the polyethylenimine, which showed the comparable delivery efficiencies in plasmid DNA, did not show significant delivery of siRNA in cervical cancer cells. These results indicate that the mechanisms involved in siRNA delivery might be different from those in plasmid DNA delivery, and that cationic lipid-based delivery vehicles deliver siRNA with higher efficiency to intracellular target sites. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 한국약제학회 | - |
dc.title | Reduction of Oncogene Expression in Cancer Cells Using siRNA Delivery Systems | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Han-Gon | - |
dc.identifier.doi | 10.4333/KPS.2005.35.5.343 | - |
dc.identifier.bibliographicCitation | 한국약제학회지, v.35, no.5, pp.343 - 348 | - |
dc.relation.isPartOf | 한국약제학회지 | - |
dc.citation.title | 한국약제학회지 | - |
dc.citation.volume | 35 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 343 | - |
dc.citation.endPage | 348 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART000973539 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | siRNA | - |
dc.subject.keywordAuthor | Delivery systems | - |
dc.subject.keywordAuthor | Polyethylenimine | - |
dc.subject.keywordAuthor | Lipofectamine | - |
dc.subject.keywordAuthor | Cervical cancer cells | - |
dc.identifier.url | https://www.koreascience.or.kr/article/JAKO200503042592091.page | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.